The case for clinical trial abundance
A supply-side reform agenda for one of our most urgent problems
Related Articles
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver
Perry et al. use a translational approach across phenotypes, outcomes, circulating proteomics, and tissue transcriptomics to identify functional biomarkers of hepatic steatosis. These markers are associated…
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma
This phase 3 randomized clinical trial evaluates whether stereotactic body radiation therapy improves outcomes in patients with locally advanced hepatocellular carcinoma compared with sorafenib alone.
Unveiled: Discovering the Truth Behind Islamic Extremism with Yasmine Mohammed
When most people hear the words Al-Qaeda, certain thoughts and images come to mind.
Primary Large B-cell Lymphomas of Immune-Privileged Sites
Diffuse large B-cell lymphoma (DLBCL) encompasses a diverse spectrum of aggressive B-cell lymphomas with remarkable genetic heterogeneity and myriad clinic
The art of storytelling in patient blood management: a narrative review on bridging the gap between complex data and understandable information
The art of storytelling in patient blood management: a narrative review on bridging the gap between complex data and understandable information
Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer
High-risk non-muscle-invasive bladder cancer (NMIBC) presents high recurrence and progression rates. Despite the use of Bacillus Calmette-Guérin gold-standard immunotherapy and the recent irruption…
Diuretic management protocol to improve quality and safety in managing acute heart failure in an integrated health system: An implementation science approach
Effective and timely decongestion in acute heart failure (AHF) coupled with careful discharge planning is critical in the successful treatment of patients hospitalized for AHF.…
A conversation with my dying father: A path forward for our country – The Boston Globe
David Gergen was recently diagnosed with Lewy body dementia. His daughter, Katherine Gergen Barnett, reveals the wisdom she received from her dying father in a…
Opinion | When Will Democrats Learn to Say No? (Gift Article)
Why supermajority thinking is urgently needed on the left.
Oncology Survivorship Care Clinics: Design and Implementation of Survivorship Care Delivery Systems at NCCN Member Institutions
Background: It is estimated that there are >18 million cancer survivors in the United States, and there is a growing number of survivorship programs across…
